Recombinant Glutamate Receptor 1 anticorps (pSer845)

N° du produit ABIN5671206

L’anticorps anti-Glutamate Receptor 1 Monoclonal Lapin est utilisé pour la détection de Glutamate Receptor 1 dans des échantillons de Humain, Rat et Souris. Il a été validé pour WB et IHC.

Aperçu rapide pour Recombinant Glutamate Receptor 1 anticorps (pSer845) (ABIN5671206)

Antigène: Glutamate Receptor 1 (GLUR1)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain, Rat, Souris

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp Glutamate Receptor 1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Clone: RM296

Détail du produit anti-Glutamate Receptor 1 anticorps

Épitope: pSer845

Fonction: Rabbit monoclonal to Phospho-Glutamate receptor 1 (GluR1) (pS845), Phospho-AMPA Receptor (GluR 1) (Ser845), Glutamate Receptor 1 (AMPA subtype) (phospho S845)

Specificité: This antibody reacts to human Glutamate Receptor 1, AMPA Receptor (GluR1) only when phosphorylated at Ser845. There is no cross-reactivity to GluR1 that is not phosphorylated at Ser845. This antibody may also react to mouse or rat Phospho-AMPA Receptor (GluR1) (Ser845) as predicted by immunogen homology.

Purification: Protein A affinity purified from an animal origin-free culture supernatant

Immunogène: A phospho-peptide corresponding to human Phospho-Glutamate Receptor 1 (GluR1) (Ser845)

Isotype: IgG

Information d'application

Indications d'application: Immunohistochemistry (IHC): 1:500-1:1000 dilution, WB: 1:1000-1:2000 dilution.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 50 % Glycerol/PBS with 1 % BSA and 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20.0°C

Détails sur Glutamate Receptor 1

Antigène: Glutamate Receptor 1 (GLUR1)

Autre désignation: AMPA Receptor (GluR 1)

ID gène: 2890

UniProt: P42261

Pathways: Signalisation PI3K-Akt